Health

Introducing the MetaSight® G200: A Revolutionary Third-Generation Chromosomal Karyotyping System Transforming Global Chromosomal Analysis

CHANGSHA, China, April 15, 2023 /PRNewswire/ -- The MetaSight® G200 is a groundbreaking karyotyping system based on high-resolution microscopy technology, capable of accurately detecting chromosomal abnormalities in humans. This innovative system aids doctors in diagnosing and treating diseases ...

2023-04-15 14:43 3091

BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS

SALT LAKE CITY, April 14, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 24,000 sq. ft. expansion of manufacturing operations at theirAthens, TX, facility. Driven by growth ...

2023-04-14 21:00 2318

Meihua International Medical Technologies Co., Ltd. Reports 2022 Financial Year Results

YANGZHOU, China, April 14, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial r...

2023-04-14 20:45 3900

Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its Global Phase 3 MRCT

* Study met both primary and all key secondary endpoints * Mean percentage change from baseline in Eczema Area and Severity Index (EASI) score was -78.7% in 1.0% MH004 Cream-treated group compared to -46.7% in vehicle group * 79.6% individuals treated with 1.0% MH004 Cream achieved EASI-75 c...

2023-04-14 19:00 6427

The Goyang International Precision Medicine Center (IPMC) takes the first step at the 2023 IPMC Conference.

SEOUL, South Korea, April 14, 2023 /PRNewswire/ -- The 2023 IPMC Conference held at KINTEX in Goyang onApril 12 under the title of "Beyond Longevity: Live 120 like 50," was successfully completed after discussing futures of the longevity industry and ways to build the Goyang Int'l Precision Medic...

2023-04-14 17:00 1946

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

SINGAPORE, April 14, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company"), a pre-clinical biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers, today announced ...

2023-04-14 08:00 4258

Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults

NANJING, China, April 13, 2023 /PRNewswire/ -- On April 1st, 2023, during the First Infection Collaboration Forum of the Chinese National Center for Infectious Diseases, Nanjing Zenshine Pharmaceuticals Co., Ltd. (Zenshine Pharmaceuticals) announced that its proprietary anti-influenza agent ZX-71...

2023-04-14 01:15 1938

Agfa Healthcare Applauded by Frost & Sullivan for Improving Workflow Effectiveness, Healthcare System Quality, and Customer Value

Agfa HealthCare offers customers cloud-based medical imaging informatics, enabling remarkable scalability, reduced complexity, and a robust rule-based engine. SAN ANTONIO, April 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the enterprise imaging industry and its evolving cloud-ba...

2023-04-13 22:00 2155

Menarini Silicon Biosystems new CELLSEARCH® data presented at AACR 2023 annual meeting highlights trailblazing contributions of liquid biopsies for cancer research

Menarini Silicon Biosystems continues to support advances in cancer research by developing new tools and solutions to automate the identification of CELLSEARCH® CTCs (Circulating Tumor Cells) through AI (Artificial Intelligence) and expand the use of liquid biopsies through the analysis of mu...

2023-04-13 20:36 1943

Healint and King's College London Announce a Ground-breaking Study on the Interaction between Sleep and Migraine in a Large Global Sample

PALO ALTO, Calif., April 13, 2023 /PRNewswire/ -- Healint, a digital health company specializing in Central Nervous System disease management has partnered with King's College London to conduct a ground-breaking study on the relationship between sleep and migraine. The study, which collected anon...

2023-04-13 20:00 1464

The Dates of the XXVII Edition of the International Fair Play Menarini Awards

FLORENCE, Italy, April 13, 2023 /PRNewswire/ -- Preparations are already underway for theInternational Fair Play Menarini Awards. This year,  the event that pays tribute to athletes who demonstrate values such as ethics, loyalty and respect both in sport and in life, is in itsXXVII edition and wi...

2023-04-13 18:50 2425

BRAND'S ESSENCE OF CHICKEN, PLUS MALAYSIA BERHAD COLLABORATES IN DRIVING ROAD SAFETY THIS FESTIVE SEASON

-  BRAND'S Essence of Chicken provides a boost of energy for all drivers going back to their hometown this Raya KUALA LUMPUR, Malaysia, April 13, 2023 /PRNewswire/ -- BRAND'S Essence of Chicken (BRAND'S) is partnering with PLUS Malaysia Berhad (PLUS) to launch the road safety campaignKekal Berte...

2023-04-13 17:37 2324

Caring Pharmacy partners with Appier to deliver a personalized multi-channel experience for Malaysians

TAIPEI, April 13, 2023 /PRNewswire/ -- Appier  (TSE: 4180) today announced the successful campaign results from its partnership with Caring Pharmacy, a leading pharmacy chain inMalaysia, to enhance its overall multi-channel marketing strategy. Caring Pharmacy enabled highl...

2023-04-13 14:00 2577

EW GROUP SHINES AT 12TH A4M SYMPOSIUM 2023 & "ALL-ON BIOREGEN OPTIMIZATION" WORKSHOP

BANGKOK, April 13, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) made a successful showing at an exclusive event, the 12th A4M Symposium 2023, which was held in Centara,Bangkok, 16th-19th February 2023. The two-day A4M Symposium, commenced with a welcome ceremony featuring ...

2023-04-13 12:20 2684

Viva Biotech Attended SAPA-China

HONG KONG, April 12, 2023 /PRNewswire/ -- 6th-7th April, the "2022 SAPA-China Annual Conference - Opportunities and Challenges for the Development ofChina's Biopharmaceutical Industry" hosted by The Sino-American Pharmaceutical Professionals Association (SAPA) was held inChengdu, Sichuan. Viva Bi...

2023-04-13 11:33 2222

Smart Physiotherapy Systems: One-Stop Solution for Pain Patients

WUHAN, China, April 12, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based inWuhan and Dusseldorf, reported the great improvement of Smart Physiotherapy Systems that were launched several ...

2023-04-13 11:10 1702

MIM Software Celebrates MTIC's First Total-Body PET/CT Scanner

The Melbourne Theronastic Innovation Centre, in partnership with Siemens Healthineers and MIM Software, will provide patients with access to a platform that will facilitate faster prognosis and personalized therapy using the world's most sensitive whole-body PET/CT scanner. CLEVELAND, April 13, ...

2023-04-13 10:48 1968

Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023

Altair will feature pharmaceutical manufacturing process simulation and data analytics technologies SEONGNAM, South Korea, April 13, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), will be exhibiting at Korea Pharm&Bio,April ...

2023-04-13 08:00 3166

Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis, cancer, and inflammation, announced it has dosed the first patient in its Phase 2a clinical study...

2023-04-13 06:00 1818

Standigm announces Younsung Choo as chief executive officer

Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmaceuticals and project management SEOUL, South Korea, April 12, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discover...

2023-04-13 00:07 2023
1 ... 242243244245246247248 ... 848